Department of Biochemistry, Pharmacology and Toxicology, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, Norwida 31, PL 50-375 Wrocław, Poland.
Pharmacol Rep. 2010 Nov-Dec;62(6):1148-58. doi: 10.1016/s1734-1140(10)70377-7.
Phosphodiesterase (PDE) inhibitors can regulate the activity of immune cells by increasing intracellular levels of cyclic nucleotides. The aim of this study was to determine the effects of milrinone, a selective PDE3 inhibitor, sildenafil, a selective PDE5 inhibitor, and aminophylline, a nonselective PDE inhibitor, on lymphocyte subsets and humoral immune response in mice when administered in vivo. Aminophylline (20 mg/kg, i.m.), milrinone (1 mg/kg, i.m.) or sildenafil (1 mg/kg, p.o.) were administered to mice either once or five times at 24 h intervals. Some mice were immunized with a sheep red blood cell (SRBC) suspension administered i.p. either 2 h after the single dose or 2 h after the second of the five doses. In non-immunized mice treated five times with PDE inhibitors, the subsets of T lymphocytes in the thymus and T and B lymphocytes in the spleen and mesenteric lymph nodes were determined 12, 24 or 72 h after the last dose. The humoral immune response was determined on days 4, 7 and 14 after SRBC injection in SRBC-immunized mice treated with PDE inhibitors. A modulating effect of the drugs on lymphocyte subpopulations was observed. The greatest impact was observed in splenocyte subpopulations, and resulted in decreased percentages of B cells (CD19(+)) and increased percentages of T cells (CD3(+), CD4(+), CD8(+)). No effect or slight influence of the drugs on anti-SRBC hemagglutinins was observed, but the number of plaque-forming splenocytes was increased. The drugs under investigation did not show a significant immunosuppressive effect.
磷酸二酯酶(PDE)抑制剂通过增加细胞内环核苷酸的水平来调节免疫细胞的活性。本研究旨在确定米力农(一种选择性 PDE3 抑制剂)、西地那非(一种选择性 PDE5 抑制剂)和氨茶碱(一种非选择性 PDE 抑制剂)在体内给药时对小鼠淋巴细胞亚群和体液免疫应答的影响。氨茶碱(20mg/kg,肌内注射)、米力农(1mg/kg,肌内注射)或西地那非(1mg/kg,口服)单次或 24 小时间隔 5 次给予小鼠。一些小鼠在单次给药后 2 小时或 5 次给药中的第二次给药后 2 小时用绵羊红细胞(SRBC)悬液经腹腔免疫。在未免疫的经 PDE 抑制剂 5 次处理的小鼠中,在最后一次给药后 12、24 或 72 小时测定胸腺 T 淋巴细胞亚群和脾和肠系膜淋巴结中的 T 和 B 淋巴细胞亚群。在经 PDE 抑制剂处理的 SRBC 免疫小鼠中,在 SRBC 注射后第 4、7 和 14 天测定体液免疫应答。药物对淋巴细胞亚群有调节作用。在脾细胞亚群中观察到最大的影响,导致 B 细胞(CD19(+))的百分比降低和 T 细胞(CD3(+)、CD4(+)、CD8(+))的百分比增加。未观察到药物对抗-SRBC 血凝素的影响或轻微影响,但脾细胞形成斑的数量增加。研究中的药物未显示出明显的免疫抑制作用。